These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30610257)

  • 1. An endothelial cell line infected by Kaposi's sarcoma-associated herpes virus (KSHV) allows the investigation of Kaposi's sarcoma and the validation of novel viral inhibitors in vitro and in vivo.
    Dubich T; Lieske A; Santag S; Beauclair G; Rückert J; Herrmann J; Gorges J; Büsche G; Kazmaier U; Hauser H; Stadler M; Schulz TF; Wirth D
    J Mol Med (Berl); 2019 Mar; 97(3):311-324. PubMed ID: 30610257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D culture conditions support Kaposi's sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells.
    Dubich T; Dittrich A; Bousset K; Geffers R; Büsche G; Köster M; Hauser H; Schulz TF; Wirth D
    J Mol Med (Berl); 2021 Mar; 99(3):425-438. PubMed ID: 33484281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.
    An FQ; Folarin HM; Compitello N; Roth J; Gerson SL; McCrae KR; Fakhari FD; Dittmer DP; Renne R
    J Virol; 2006 May; 80(10):4833-46. PubMed ID: 16641275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
    Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
    J Virol; 2017 May; 91(10):. PubMed ID: 28275189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
    Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
    Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
    PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
    Medveczky MM; Horvath E; Lund T; Medveczky PG
    AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
    Gramolelli S; Ojala PM
    Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus vFLIP promotes MEndT to generate hybrid M/E state for tumorigenesis.
    Chen W; Ding Y; Liu D; Lu Z; Wang Y; Yuan Y
    PLoS Pathog; 2021 Dec; 17(12):e1009600. PubMed ID: 34936683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oroxylin A inhibits Kaposi's sarcoma-associated herpes virus (KSHV) vIL-6-mediated lymphatic reprogramming of vascular endothelial cells through modulating PPARγ/Prox1 axis.
    Zhu X; Chen Y; Zhu W; Ji M; Xu J; Guo Y; Gao F; Gu W; Yang X; Zhang C
    J Med Virol; 2019 Mar; 91(3):463-472. PubMed ID: 30318784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.
    Dictor M; Rambech E; Way D; Witte M; Bendsöe N
    Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of HDAC5 by Viral Interferon Regulatory Factor 3 Plays an Essential Role in Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphangiogenesis.
    Lee HR; Li F; Choi UY; Yu HR; Aldrovandi GM; Feng P; Gao SJ; Hong YK; Jung JU
    mBio; 2018 Jan; 9(1):. PubMed ID: 29339432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.
    Sharma-Walia N; Paul AG; Bottero V; Sadagopan S; Veettil MV; Kerur N; Chandran B
    PLoS Pathog; 2010 Feb; 6(2):e1000777. PubMed ID: 20169190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
    Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
    Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.
    Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA
    Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated herpesvirus downregulates transforming growth factor β2 to promote enhanced stability of capillary-like tube formation.
    DiMaio TA; Gutierrez KD; Lagunoff M
    J Virol; 2014 Dec; 88(24):14301-9. PubMed ID: 25275137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
    Watanabe T; Fujimuro M
    Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.